DR 273 (151894-45-0)
Identification |
Properties |
Safety Data |
|
|
Other Product
- separan AP 273
- Antibiotic 273 (9CI)
- Direct blue 273
- SL 72-273
- DR 260
- DR 28
- DR 261
- benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride(dr>98/2)
- Antigen HLA-DR-BON(human clone HLA-DRB1*BON b-chain protein moiety reduced) (9CI)
- 3-(Dr-1tF,2cF,3rF,4-tetrahydroxy-but-catF-yl)-1H-quinoxalin-2-one
- 1H-Pyrrole-1-heptanoicacid, b,d-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-,(bR,dR)-
- 1-Naphthaleneheptanoicacid, 1,2,3,5,6,7,8,8a-octahydro-b,d,3-trihydroxy-2,6-dimethyl-,[1R-[1a(bR*,dR*),2a,3b,6b,8aa]]- (9CI)
- 1-Naphthaleneheptanoicacid, 1,2,3,5,6,7,8,8a-octahydro-b,d,3-trihydroxy-2-methyl-,monosodium salt, [1R-[1a(bR*,dR*),2a,3b,8aa]]- (9CI)
- 1H-Pyrrole-1-heptanoicacid, 2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,(bR,dR)-rel-
- 1H-Pyrrole-1-heptanoicacid, 2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,sodium salt (1:1), (bR,dR)-
- 1-Naphthaleneheptanoicacid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-b,d-dihydroxy-2,6-dimethyl-, ammonium salt (1:1), (bR,dR,1S,2S,6R,8S,8aR)-
- 1-Naphthaleneheptanoicacid, 1,2,6,7,8,8a-hexahydro-b,d,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-,4-(nitrooxy)butyl ester, (bR,dR,1S,2S,6S,8S,8aR)-
- 1-Naphthaleneheptanoicacid, 1,2,6,7,8,8a-hexahydro-b,d,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-,(bR,dR,1S,2S,6S,8S,8aR)-
- Immunoglobulin G1,anti-(human histocompatibility antigen HLA-DR) (human-mouse monoclonal Hu1D10 g1-chain), disulfide withhuman-mouse monoclonal Hu1D10 light chain, dimer
- 1H-Pyrrole-1-heptanoicacid, 2-(4-fluorophenyl)-b,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-,(bR,dR)-